Silence Therapeutics Plc (SLNCF)
1.06
-0.39
(-27.02%)
USD |
OTCM |
May 20, 15:59
Silence Therapeutics Shareholders Equity (Quarterly) : 49.40M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Adaptimmune Therapeutics Plc | -70.96M |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | 29.50M |
| Kiniksa Pharmaceuticals International Plc | 605.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.12M |
| Total Liabilities (Quarterly) | 65.72M |
| Debt to Equity Ratio | 0.0028 |
| Current Ratio | 9.833 |
| Net Debt Paydown Yield | 0.00% |